A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.

Campos, Susana M; Brady, William E; Moxley, Katherine M; O'Cearbhaill, Roisin E; Lee, Paula S; DiSilvestro, Paul A; Rotmensch, Jacob; Rose, Peter G; Thaker, Premal H; O'Malley, David M; Hanjani, Parviz; Zuna, Rosemary E; Hensley, Martee L.
Gynecol Oncol; 133(3): 537-41, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24594074